Ȩ > ±Û·Î¹úÆÄÆ®³Ê > DelveInsight Business Research LLP

DelveInsight Business Research LLP

±Û·Î¹úÀÎÆ÷¸ÞÀ̼ÇÀº DelveInsight Business Research LLPÀÇ Çѱ¹ ÆÄÆ®³ÊÀÔ´Ï´Ù. DelveInsight Business Research LLP°¡ ¹ßÇàÇÏ´Â ½ÃÀå º¸°í¼­¸¦ ÆÇ¸ÅÇϰí ÀÖ½À´Ï´Ù. °Ë»öµÇÁö ¾Ê´Â ÀÚ·áµµ ÁÖ¹® °¡´ÉÇÏ´Ï ¹®ÀÇÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
DelveInsight´Â Á¦¾à ¹× »ý¸í °øÇÐ »ê¾÷À» Áß½ÉÀ¸·Î »ý¸í°úÇÐ »ê¾÷ÀÇ ±íÀÌ ÀÖ´Â Àü¹®¼ºÀ» °®Ãá ºñÁî´Ï½º ÄÁ¼³ÆÃ ȸ»çÀÔ´Ï´Ù. °í°´ÀÌ º¸´Ù ³ªÀº ºñÁî´Ï½º ÀÇ»ç °áÁ¤À» ³»¸®°í ¼º°ú¸¦ ¸¸µé ¼ö ÀÖµµ·Ï ÃÖ°íÀÇ ¼­ºñ½º¿Í ºü¸¥ ½ÃÀå µ¿Çâ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.
°Ë»ö
Á¦¸ñ°Ë»ö
1 - 25 ¸®ºä (Àüü£º 2551 °Ç) Á¤·Ä Ç¥½Ã °Ç¼ö
CDK4/6 Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1745751
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
120 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 7,950 -> £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
Phosphoinositide 3-kinase inhibitors (PI3K) - Target Population, Competitive Landscape, and Market Forecast - 2034
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1745750
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
120 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 7,950 -> £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
SERD Market Size, Target Population, Competitive Landscape & Market Forecast - 2034
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1745752
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
120 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 7,950 -> £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
Prostate-Specific Membrane Antigen (PSMA) Targeted Therapy - Target Population, Competitive Landscape, and Market Forecast - 2034
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1745753
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
120 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 7,950 -> £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
Anaplastic Lymphoma Kinase (ALK) Targeted Therapies - Target Population, Competitive Landscape, and Market Forecast - 2034
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1745754
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
120 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 7,950 -> £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
B-rapidly Accelerated Fibrosarcoma (BRAF) Targeted Therapies - Target Population, Competitive Landscape, and Market Forecast - 2034
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1745755
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
120 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 7,950 -> £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
ROS Proto-oncogene 1 (ROS-1) Inhibitors -Target Population, Competitive Landscape, and Market Forecast-2034
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1745756
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
120 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 7,950 -> £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
Lymphocyte-Activation Gene 3 (LAG-3) -Target Population, Competitive Landscape, and Market Forecast-2034
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1745757
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
120 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 7,950 -> £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
Anti-CD38 mAb Market Size, Target Population, Competitive Landscape & Market Forecast - 2034
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1745758
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
120 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 7,950 -> £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
B7-H4 Targeting Therapies - Market Size, Target Population, Competitive Landscape & Market Forecast - 2040
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1745759
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
120 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 7,950 -> £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
Tyrosine kinase 2 (TYK2) Inhibitors - Target Population, Competitive Landscape, and Market Forecast - 2034
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1745760
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
120 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 7,950 -> £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
Receptor-interacting Protein Kinase 1 (RIPK1) Inhibitors - Target Population, Competitive Landscape, and Market Forecast - 2034
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1745761
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
120 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 7,950 -> £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
Delta-like Ligand 3 (DLL3)-targeted Therapies - Target Population, Competitive Landscape, and Market Forecast - 2034
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1745762
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
120 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 7,950 -> £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
BAFF- and APRIL-targeted Therapies - Target Population, Competitive Landscape, and Market Forecast - 2034
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1745763
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
120 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 7,950 -> £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
Anti- C-C Motif Chemokine Receptor 8 (CCR8) Antibodies - Target Population, Competitive Landscape, and Market Forecast - 2040
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1745764
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
120 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 7,950 -> £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
Dihydroorotate Dehydrogenase (DHODH) Inhibitor- Target Population, Competitive Landscape, and Market Forecast - 2034
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1745765
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
120 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 7,950 -> £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
GPCR-Targeting Therapies - Target Population, Competitive Landscape, and Market Forecast - 2034
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1745766
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
120 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 7,950 -> £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
NADPH Oxidase (NOX)-Replacement Therapies - Target Population, Competitive Landscape, and Market Forecast - 2034
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1745767
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
120 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 7,950 -> £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
PARP Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1745768
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
120 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 7,950 -> £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
HSV-1 Keratitis- Competitive landscape, 2025
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1727035
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
60 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 1,250 -> £Ü 1,815,000 (ºÎ°¡¼¼ º°µµ)
Checkpoint Inhibitors - Competitive landscape, 2025
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1727029
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
180 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 2,500 -> £Ü 3,631,000 (ºÎ°¡¼¼ º°µµ)
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1727034
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
280 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 3,000 -> £Ü 4,357,000 (ºÎ°¡¼¼ º°µµ)
Multiple Sclerosis - Competitive landscape, 2025
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1727036
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
280 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 3,000 -> £Ü 4,357,000 (ºÎ°¡¼¼ º°µµ)
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1727027
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
450 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 5,000 -> £Ü 7,262,000 (ºÎ°¡¼¼ º°µµ)
¸®¼­Ä¡»ç
DelveInsight Business Research LLP
»óǰÄÚµå
1727069
¹ßÇàÀÏ
On Demand Report
ÆäÀÌÁö Á¤º¸
80 PagesImage  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 2,000 -> £Ü 2,904,000 (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦